BOUNDLESS BIO, INC.

Altre lingue Boundless Bio, Inc.

Azioni

BOLD

US10170A1007

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 17/05/2024			Variaz. 5gg	Var. 1 gen.
9,67 ^USD	-2,91%		+12,57%	0,00%

23/04	BOUNDLESS BIO, INC. : Guggenheim conferma il rating Buy	ZM
23/04	BOUNDLESS BIO, INC. : Piper Sandler ancora positivo	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights	13/05
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024	06/05
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	11/04
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	11/04
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA -Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	09/04
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	08/04
Boundless Bio Insider Bought Shares Worth $3,200,000, According to a Recent SEC Filing	04/04
Boundless Bio Insider Bought Shares Worth $3,200,000, According to a Recent SEC Filing	04/04
Boundless Bio, Inc.(NasdaqGS:BOLD) added to NASDAQ Composite Index	01/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Tutti i resoconti di oltre 9.000 società, il giorno stesso della pubblicazione!

fermer